Bowyer, S., Prithviraj, P., Lorigan, P., Larkin, J., McArthur, G., Atkinson, V., . . . Klein, O. (2017). Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''. Br J Cancer.
Chicago Stili AlıntıBowyer, Samantha, et al. "Reply to ‘Comment On ‘Efficacy and Toxicity of Treatment With the Anti-CTLA-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-PD-1 Therapy''." Br J Cancer 2017.
MLA AlıntıBowyer, Samantha, et al. "Reply to ‘Comment On ‘Efficacy and Toxicity of Treatment With the Anti-CTLA-4 Antibody Ipilimumab in Patients With Metastatic Melanoma After Prior Anti-PD-1 Therapy''." Br J Cancer 2017.